Morepen Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

19 Jul 2018 | 03:59 PM

25.65
-0.65 (-2.47%)

  • Outperforms Index

    35.36%

    Return (1Y)

    Beaten S&P BSE Healthcare by 45.37%

  • More Volatile

    4.15%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 3.05%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

44

44.35

15

14.80

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Morepen Laboratories Ltd has increased by 11400% since past 1 Year

Loading...